O	0	10	Expression	Expression	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	19	KISS1	KISS1	NN	B-NP
O	20	23	and	and	CC	I-NP
O	24	27	MMP	MMP	NN	I-NP
O	27	28	-	-	HYPH	O
O	28	29	9	9	CD	B-NP
O	30	32	in	in	IN	B-PP
B-Cancer	33	36	non	non	AFX	B-NP
I-Cancer	36	37	-	-	HYPH	I-NP
I-Cancer	37	42	small	small	JJ	B-NP
I-Cancer	43	47	cell	cell	NN	I-NP
I-Cancer	48	52	lung	lung	NN	I-NP
I-Cancer	53	59	cancer	cancer	NN	I-NP
O	60	63	and	and	CC	O
O	64	69	their	their	PRP$	B-NP
O	70	79	relations	relation	NNS	I-NP
O	80	82	to	to	TO	B-PP
O	83	93	metastasis	metastasis	NN	B-NP
O	94	97	and	and	CC	I-NP
O	98	106	survival	survival	NN	I-NP
O	106	107	.	.	.	O

O	109	114	KISS1	KISS1	NN	B-NP
O	115	118	and	and	CC	I-NP
O	119	125	matrix	matrix	NN	I-NP
O	126	143	metalloproteinase	metalloproteinase	NN	I-NP
O	143	144	-	-	HYPH	O
O	144	145	9	9	CD	B-NP
O	146	147	(	(	(	O
O	147	150	MMP	MMP	NN	B-NP
O	150	151	-	-	HYPH	B-NP
O	151	152	9	9	CD	I-NP
O	152	153	)	)	)	O
O	154	157	may	may	MD	B-VP
O	158	162	play	play	VB	I-VP
O	163	172	important	important	JJ	B-NP
O	173	178	roles	role	NNS	I-NP
O	179	181	as	as	IN	B-PP
O	182	192	metastasis	metastasis	NN	B-NP
O	193	203	suppressor	suppressor	NN	I-NP
O	204	207	and	and	CC	I-NP
O	208	218	metastasis	metastasis	NN	I-NP
O	219	227	promoter	promoter	NN	I-NP
O	228	233	genes	gene	NNS	I-NP
O	233	234	,	,	,	O
O	235	247	respectively	respectively	RB	B-ADVP
O	247	248	,	,	,	O
O	249	251	in	in	IN	B-PP
O	252	253	a	a	DT	B-NP
O	254	261	variety	variety	NN	I-NP
O	262	264	of	of	IN	B-PP
B-Cancer	265	277	malignancies	malignancy	NNS	B-NP
O	277	278	.	.	.	O

O	279	286	However	However	RB	B-ADVP
O	286	287	,	,	,	O
O	288	293	there	there	EX	B-NP
O	294	296	is	be	VBZ	B-VP
O	297	303	little	little	JJ	B-NP
O	304	315	information	information	NN	I-NP
O	316	321	about	about	IN	B-PP
O	322	327	their	their	PRP$	B-NP
O	328	336	possible	possible	JJ	I-NP
O	337	342	roles	role	NNS	I-NP
O	343	345	in	in	IN	B-PP
B-Cancer	346	349	non	non	AFX	B-NP
I-Cancer	349	350	-	-	HYPH	I-NP
I-Cancer	350	355	small	small	JJ	B-NP
I-Cancer	356	360	cell	cell	NN	I-NP
I-Cancer	361	365	lung	lung	NN	I-NP
I-Cancer	366	372	cancer	cancer	NN	I-NP
O	373	374	(	(	(	O
B-Cancer	374	379	NSCLC	NSCLC	NN	B-NP
O	379	380	)	)	)	O
O	380	381	.	.	.	O

O	382	385	The	The	DT	B-NP
O	386	391	goals	goal	NNS	I-NP
O	392	394	of	of	IN	B-PP
O	395	399	this	this	DT	B-NP
O	400	405	study	study	NN	I-NP
O	406	410	were	be	VBD	B-VP
O	411	413	to	to	TO	I-VP
O	414	423	determine	determine	VB	I-VP
O	424	427	the	the	DT	B-NP
O	428	432	mRNA	mRNA	NN	I-NP
O	433	436	and	and	CC	I-NP
O	437	444	protein	protein	NN	I-NP
O	445	456	expressions	expression	NNS	I-NP
O	457	459	of	of	IN	B-PP
O	460	465	KISS1	KISS1	NN	B-NP
O	466	469	and	and	CC	I-NP
O	470	473	MMP	MMP	NN	I-NP
O	473	474	-	-	HYPH	O
O	474	475	9	9	CD	B-NP
O	476	478	in	in	IN	B-PP
B-Cancer	479	484	NSCLC	NSCLC	NN	B-NP
O	485	488	and	and	CC	O
O	489	494	their	their	PRP$	B-NP
O	495	504	relations	relation	NNS	I-NP
O	505	507	to	to	TO	B-PP
O	508	518	metastasis	metastasis	NN	B-NP
O	519	522	and	and	CC	I-NP
O	523	532	prognosis	prognosis	NN	I-NP
O	532	533	.	.	.	O

O	534	537	The	The	DT	B-NP
O	538	542	mRNA	mRNA	NN	I-NP
O	543	546	and	and	CC	I-NP
O	547	554	protein	protein	NN	I-NP
O	555	566	expressions	expression	NNS	I-NP
O	567	569	of	of	IN	B-PP
O	570	575	KISS1	KISS1	NN	B-NP
O	576	579	and	and	CC	B-PP
O	580	582	of	of	IN	B-PP
O	583	586	MMP	MMP	NN	B-NP
O	586	587	-	-	HYPH	B-NP
O	587	588	9	9	CD	I-NP
O	589	596	protein	protein	NN	I-NP
O	597	601	were	be	VBD	B-VP
O	602	610	detected	detect	VBN	I-VP
O	611	613	by	by	IN	B-PP
O	614	616	in	in	FW	B-NP
O	617	621	situ	situ	FW	I-NP
O	622	635	hybridization	hybridization	NN	I-NP
O	636	639	and	and	CC	I-NP
O	640	660	immunohistochemistry	immunohistochemistry	NN	I-NP
O	661	673	respectively	respectively	RB	B-ADVP
O	674	676	in	in	IN	B-PP
O	677	679	85	85	CD	B-NP
O	680	685	cases	case	NNS	I-NP
O	686	688	of	of	IN	B-PP
B-Cancer	689	694	NSCLC	NSCLC	NN	B-NP
O	694	695	,	,	,	O
O	696	699	and	and	CC	O
O	700	705	their	their	PRP$	B-NP
O	706	713	matched	match	VBN	I-NP
B-Cancer	714	719	lymph	lymph	NN	I-NP
I-Cancer	720	724	node	node	NN	I-NP
I-Cancer	725	735	metastases	metastasis	NNS	I-NP
O	735	736	.	.	.	O

O	737	748	Expressions	Expression	NNS	B-NP
O	749	751	of	of	IN	B-PP
O	752	757	KISS1	KISS1	NN	B-NP
O	758	762	mRNA	mRNA	NN	I-NP
O	763	766	and	and	CC	I-NP
O	767	774	protein	protein	NN	I-NP
O	775	779	were	be	VBD	B-VP
O	780	793	significantly	significantly	RB	B-ADJP
O	794	800	higher	high	JJR	I-ADJP
O	801	803	in	in	IN	B-PP
O	804	807	low	low	JJ	B-NP
O	808	811	TNM	TNM	NN	I-NP
O	812	818	stages	stage	NNS	I-NP
O	819	821	of	of	IN	B-PP
B-Cancer	822	827	NSCLC	NSCLC	NN	B-NP
O	828	829	(	(	(	O
O	829	830	I	I	NN	B-NP
O	830	831	-	-	HYPH	O
O	831	833	II	II	CD	B-NP
O	833	834	)	)	)	O
O	835	843	compared	compare	VBN	B-VP
O	844	846	to	to	TO	B-PP
O	847	851	more	more	RBR	B-NP
O	852	860	advanced	advanced	JJ	I-NP
O	861	867	stages	stage	NNS	I-NP
O	868	869	(	(	(	O
O	869	872	III	III	CD	B-NP
O	872	873	-	-	HYPH	I-NP
O	873	875	IV	IV	CD	I-NP
O	875	876	)	)	)	O
O	877	878	(	(	(	O
O	878	879	p	p	NN	B-NP
O	879	880	<	<	SYM	B-ADJP
O	880	881	0	0	CD	B-NP
O	881	882	.	.	.	I-NP
O	882	884	05	05	CD	I-NP
O	884	885	)	)	)	O
O	885	886	.	.	.	O

O	887	895	Moreover	Moreover	RB	B-ADVP
O	895	896	,	,	,	O
O	897	899	in	in	IN	B-PP
O	900	908	advanced	advance	VBN	B-NP
O	909	912	TNM	TNM	NN	I-NP
O	913	919	stages	stage	NNS	I-NP
O	919	920	,	,	,	O
O	921	926	cases	case	NNS	B-NP
O	927	934	without	without	IN	B-PP
O	935	945	metastasis	metastasis	NN	B-NP
O	946	949	had	have	VBD	B-VP
O	950	956	higher	high	JJR	B-NP
O	957	962	KISS1	KISS1	NN	I-NP
O	963	967	gene	gene	NN	I-NP
O	968	978	expression	expression	NN	I-NP
O	979	987	compared	compare	VBN	B-VP
O	988	990	to	to	TO	B-PP
O	991	996	those	those	DT	B-NP
O	997	1001	with	with	IN	B-PP
B-Multi-tissue_structure	1002	1007	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1008	1012	node	node	NN	I-NP
O	1013	1023	metastasis	metastasis	NN	I-NP
O	1024	1025	(	(	(	O
O	1025	1026	p	p	NN	B-NP
O	1026	1027	<	<	SYM	B-ADJP
O	1027	1028	0	0	CD	B-NP
O	1028	1029	.	.	.	I-NP
O	1029	1031	05	05	CD	I-NP
O	1031	1032	)	)	)	O
O	1032	1033	.	.	.	O

O	1034	1036	In	In	IN	B-PP
O	1037	1045	contrast	contrast	NN	B-NP
O	1045	1046	,	,	,	O
O	1047	1050	MMP	MMP	NN	B-NP
O	1050	1051	-	-	HYPH	O
O	1051	1052	9	9	CD	B-NP
O	1053	1063	expression	expression	NN	I-NP
O	1064	1067	was	be	VBD	B-VP
O	1068	1074	higher	high	JJR	B-ADJP
O	1075	1077	in	in	IN	B-PP
O	1078	1083	stage	stage	NN	B-NP
O	1084	1087	III	III	CD	I-NP
O	1087	1088	-	-	HYPH	I-NP
O	1088	1090	IV	IV	CD	I-NP
B-Cancer	1091	1096	NSCLC	NSCLC	NN	I-NP
O	1097	1102	cases	case	NNS	I-NP
O	1103	1111	compared	compare	VBN	B-VP
O	1112	1114	to	to	TO	B-PP
O	1115	1120	stage	stage	NN	B-NP
O	1121	1122	I	I	CD	I-NP
O	1122	1123	-	-	HYPH	I-NP
O	1123	1125	II	II	CD	I-NP
B-Cancer	1126	1132	tumors	tumor	NNS	I-NP
O	1133	1134	(	(	(	O
O	1134	1135	p	p	NN	B-NP
O	1135	1136	<	<	SYM	B-ADJP
O	1136	1137	0	0	CD	B-NP
O	1137	1138	.	.	.	I-NP
O	1138	1140	05	05	CD	I-NP
O	1140	1141	)	)	)	O
O	1142	1145	and	and	CC	O
O	1146	1152	higher	high	JJR	B-ADJP
O	1153	1155	in	in	IN	B-PP
B-Cancer	1156	1161	NSCLC	NSCLC	NN	B-NP
O	1162	1167	cases	case	NNS	I-NP
O	1168	1172	with	with	IN	B-PP
O	1173	1183	metastasis	metastasis	NN	B-NP
O	1184	1188	than	than	IN	B-PP
O	1189	1194	those	those	DT	B-NP
O	1195	1202	without	without	IN	B-PP
O	1203	1213	metastasis	metastasis	NN	B-NP
O	1214	1215	(	(	(	O
O	1215	1216	p	p	NN	B-NP
O	1216	1217	<	<	SYM	B-ADJP
O	1217	1218	0	0	CD	B-NP
O	1218	1219	.	.	.	I-NP
O	1219	1221	05	05	CD	I-NP
O	1221	1222	)	)	)	O
O	1222	1223	.	.	.	O

O	1224	1229	There	There	EX	B-NP
O	1230	1233	was	be	VBD	B-VP
O	1234	1242	negative	negative	JJ	B-NP
O	1243	1253	correction	correction	NN	I-NP
O	1254	1261	between	between	IN	B-PP
O	1262	1267	KISS1	KISS1	NN	B-NP
O	1268	1271	and	and	CC	I-NP
O	1272	1275	MMP	MMP	NN	I-NP
O	1275	1276	-	-	HYPH	O
O	1276	1277	9	9	CD	B-NP
O	1278	1285	protein	protein	NN	I-NP
O	1286	1296	expression	expression	NN	I-NP
O	1297	1298	(	(	(	O
O	1298	1299	p	p	NN	B-NP
O	1299	1300	<	<	SYM	B-ADJP
O	1300	1301	0	0	CD	B-NP
O	1301	1302	.	.	.	I-NP
O	1302	1304	01	01	CD	I-NP
O	1304	1305	)	)	)	O
O	1305	1306	.	.	.	O

O	1307	1310	The	The	DT	B-NP
O	1311	1312	5	5	CD	I-NP
O	1312	1313	-	-	HYPH	I-NP
O	1313	1317	year	year	NN	I-NP
O	1318	1326	survival	survival	NN	I-NP
O	1327	1331	rate	rate	NN	I-NP
O	1332	1334	in	in	IN	B-PP
O	1335	1340	cases	case	NNS	B-NP
O	1341	1345	with	with	IN	B-PP
O	1346	1352	higher	high	JJR	B-NP
O	1353	1358	KISS1	KISS1	NN	I-NP
O	1359	1366	protein	protein	NN	I-NP
O	1367	1377	expression	expression	NN	I-NP
O	1378	1381	was	be	VBD	B-VP
O	1382	1395	significantly	significantly	RB	B-ADJP
O	1396	1402	higher	high	JJR	I-ADJP
O	1403	1407	than	than	IN	B-PP
O	1408	1410	in	in	IN	B-PP
O	1411	1416	those	those	DT	B-NP
O	1417	1421	with	with	IN	B-PP
O	1422	1425	low	low	JJ	B-NP
O	1426	1436	expression	expression	NN	I-NP
O	1437	1438	(	(	(	O
O	1438	1440	20	20	CD	B-NP
O	1440	1441	.	.	.	O
O	1441	1442	9	9	CD	B-NP
O	1443	1445	vs	v	NNS	I-NP
O	1445	1446	.	.	.	O
O	1447	1448	2	2	CD	B-NP
O	1448	1449	.	.	.	O
O	1449	1450	4	4	CD	B-NP
O	1450	1451	%	%	NN	I-NP
O	1451	1452	,	,	,	O
O	1453	1454	p	p	NN	B-NP
O	1454	1455	<	<	SYM	B-VP
O	1455	1456	0	0	CD	B-NP
O	1456	1457	.	.	.	I-NP
O	1457	1459	01	01	CD	I-NP
O	1459	1460	)	)	)	O
O	1460	1461	.	.	.	O

O	1462	1469	However	However	RB	B-ADVP
O	1469	1470	,	,	,	O
O	1471	1474	the	the	DT	B-NP
O	1475	1476	5	5	CD	I-NP
O	1476	1477	-	-	HYPH	I-NP
O	1477	1481	year	year	NN	I-NP
O	1482	1490	survival	survival	NN	I-NP
O	1491	1495	rate	rate	NN	I-NP
O	1496	1498	of	of	IN	B-PP
O	1499	1507	patients	patient	NNS	B-NP
O	1508	1512	with	with	IN	B-PP
O	1513	1517	high	high	JJ	B-NP
O	1518	1521	MMP	MMP	NN	I-NP
O	1521	1522	-	-	HYPH	B-NP
O	1522	1523	9	9	CD	I-NP
O	1524	1531	protein	protein	NN	I-NP
O	1532	1542	expression	expression	NN	I-NP
O	1543	1547	were	be	VBD	B-VP
O	1548	1553	lower	low	JJR	B-ADJP
O	1554	1558	than	than	IN	B-PP
O	1559	1564	those	those	DT	B-NP
O	1565	1569	with	with	IN	B-PP
O	1570	1573	low	low	JJ	B-NP
O	1574	1584	expression	expression	NN	I-NP
O	1585	1586	(	(	(	O
O	1586	1588	19	19	CD	B-NP
O	1589	1591	vs	v	NNS	I-NP
O	1591	1592	.	.	.	O
O	1593	1594	4	4	CD	B-NP
O	1594	1595	.	.	.	O
O	1595	1596	7	7	CD	B-NP
O	1596	1597	%	%	NN	I-NP
O	1597	1598	,	,	,	O
O	1599	1600	p	p	NN	B-NP
O	1600	1601	<	<	SYM	B-VP
O	1601	1602	0	0	CD	B-NP
O	1602	1603	.	.	.	I-NP
O	1603	1605	05	05	CD	I-NP
O	1605	1606	)	)	)	O
O	1606	1607	.	.	.	O

O	1608	1611	Our	Our	PRP$	B-NP
O	1612	1616	data	datum	NNS	I-NP
O	1617	1624	suggest	suggest	VBP	B-VP
O	1625	1629	that	that	IN	B-SBAR
O	1630	1635	KISS1	KISS1	NN	B-NP
O	1636	1639	and	and	CC	I-NP
O	1640	1643	MMP	MMP	NN	I-NP
O	1643	1644	-	-	HYPH	O
O	1644	1645	9	9	CD	B-NP
O	1646	1649	may	may	MD	B-VP
O	1650	1655	serve	serve	VB	I-VP
O	1656	1658	as	as	IN	B-PP
O	1659	1668	potential	potential	JJ	B-NP
O	1669	1679	prognostic	prognostic	JJ	I-NP
O	1680	1683	and	and	CC	I-NP
O	1684	1695	therapeutic	therapeutic	JJ	I-NP
O	1696	1703	markers	marker	NNS	I-NP
O	1704	1706	in	in	IN	B-PP
B-Cancer	1707	1711	lung	lung	NN	B-NP
I-Cancer	1712	1718	cancer	cancer	NN	I-NP
O	1718	1719	.	.	.	O

